Nanobiotix S.A. Postemployment Benefit Expense Defined Benefit Plans
Nanobiotix S.A. (NNBXF) reported Postemployment Benefit Expense Defined Benefit Plans of EUR 95.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2026-03-31
| Period end | Postemployment Benefit Expense Defined Benefit Plans 6 month | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|---|
| 2025-12-31 | 95.00K EUR 20-F · filed 2026-03-31 | |
| 2024-12-31 | 76.00K EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 38.00K EUR 6-K · filed 2024-09-18 | |
| 2023-12-31 | 75.00K EUR 20-F · filed 2025-04-02 | |
| 2023-06-30 | 38.00K EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 78.00K EUR 20-F · filed 2024-04-24 | |
| 2022-06-30 | 38.00K EUR 6-K · filed 2022-09-28 | |
| 2021-12-31 | 85.00K EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | 43.00K EUR 6-K · filed 2021-09-08 | |
| 2020-12-31 | 79.00K EUR 20-F · filed 2023-04-24 | |
| 2019-12-31 | 82.00K EUR 20-F/A · filed 2021-04-08 |